Eric Burton

1.2k total citations
41 papers, 784 citations indexed

About

Eric Burton is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Eric Burton has authored 41 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Eric Burton's work include Glioma Diagnosis and Treatment (25 papers), Brain Metastases and Treatment (13 papers) and Meningioma and schwannoma management (9 papers). Eric Burton is often cited by papers focused on Glioma Diagnosis and Treatment (25 papers), Brain Metastases and Treatment (13 papers) and Meningioma and schwannoma management (9 papers). Eric Burton collaborates with scholars based in United States, United Kingdom and Poland. Eric Burton's co-authors include Michael D. Prados, Alan G. Glaros, Shiao Y. Woo, Ken Aldape, Mehran Yusuf, James N. Scott, Sandra Passe, Robert B. Jenkins, Kathleen R. Lamborn and Peter Forsyth and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Neurology.

In The Last Decade

Eric Burton

41 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Burton United States 14 404 207 205 186 148 41 784
Yuriko Minn United States 4 578 1.4× 341 1.6× 233 1.1× 135 0.7× 227 1.5× 5 997
Paul L. Moots United States 13 424 1.0× 144 0.7× 133 0.6× 80 0.4× 90 0.6× 26 792
Young Zoon Kim South Korea 13 262 0.6× 214 1.0× 231 1.1× 107 0.6× 85 0.6× 57 714
Jasper Chen United States 11 125 0.3× 433 2.1× 76 0.4× 245 1.3× 336 2.3× 14 1.3k
Konstantinos Gousias Germany 13 301 0.7× 250 1.2× 98 0.5× 93 0.5× 109 0.7× 29 739
Kiyoshi Onda Japan 16 464 1.1× 186 0.9× 198 1.0× 93 0.5× 71 0.5× 38 832
Tomoyuki Koga Japan 20 269 0.7× 266 1.3× 134 0.7× 110 0.6× 141 1.0× 61 1.1k
Takafumi Ide Japan 14 237 0.6× 281 1.4× 146 0.7× 60 0.3× 119 0.8× 33 797
Seon‐Jin Yoon South Korea 14 370 0.9× 416 2.0× 163 0.8× 162 0.9× 317 2.1× 37 988

Countries citing papers authored by Eric Burton

Since Specialization
Citations

This map shows the geographic impact of Eric Burton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Burton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Burton more than expected).

Fields of papers citing papers by Eric Burton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Burton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Burton. The network helps show where Eric Burton may publish in the future.

Co-authorship network of co-authors of Eric Burton

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Burton. A scholar is included among the top collaborators of Eric Burton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Burton. Eric Burton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hieken, Tina J., Shahneen Sandhu, Zeynep Eroglu, et al.. (2024). LBA41 Long-term survival with neoadjuvant therapy in melanoma: Updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC). Annals of Oncology. 35. S1232–S1232. 8 indexed citations
2.
Cozzi, Francesca, et al.. (2023). A case of disseminated spinal astroblastoma harboring a MAMLD1::BEND2 fusion. Neuropathology. 44(4). 278–284. 4 indexed citations
3.
Cozzi, F., et al.. (2023). Glioblastoma may evade immune surveillance through primary cilia-dependent signaling in an IL-6 dependent manner. Frontiers in Oncology. 13. 1279923–1279923. 5 indexed citations
4.
Yusuf, Mehran, Abbas Rattani, Jeremy Gaskins, et al.. (2021). Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy. Journal of Neuro-Oncology. 156(1). 163–172. 8 indexed citations
5.
Zimmer, Alexandra S., Seth M. Steinberg, Dee Dee Smart, et al.. (2020). Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases. Future Oncology. 16(14). 899–909. 21 indexed citations
6.
King, Paul D., Xiaohui Li, Charles D. Anderson, et al.. (2019). Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells. Journal of Neuro-Oncology. 143(2). 231–240. 9 indexed citations
7.
Shephard, Michael, Lauren E. Haydu, Rodabe N. Amaria, et al.. (2019). Outcomes of patients with melanoma brain metastases (MBM) treated with standard of care therapy after being excluded from MBM-specific clinical trials. Annals of Oncology. 30. v555–v555. 1 indexed citations
8.
Amsbaugh, Mark J., Mehran Yusuf, Jeremy Gaskins, Eric Burton, & Shiao Y. Woo. (2019). The impact of timing of adjuvant therapy on survival for patients with glioblastoma: An analysis of the National Cancer Database. Journal of Clinical Neuroscience. 66. 92–99. 9 indexed citations
9.
Muluhngwi, Penn, Roland Valdes, Rafael Fernandez-Botrán, et al.. (2019). Cell-Free DNA Diagnostics: Current and Emerging Applications in Oncology. Pharmacogenomics. 20(5). 357–380. 14 indexed citations
10.
Chen, Yiren, Beatrice Ugiliweneza, Eli Johnson, et al.. (2018). National Trends for Reoperation in Older Patients with Glioblastoma. World Neurosurgery. 113. e179–e189. 15 indexed citations
11.
Amsbaugh, Mark J., Mehran Yusuf, Jeremy Gaskins, Eric Burton, & Shiao Y. Woo. (2017). Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base. Cancer. 123(17). 3277–3284. 21 indexed citations
12.
Yusuf, Mehran, Mark J. Amsbaugh, Eric Burton, et al.. (2017). Postoperative Stereotactic Radiation Therapy for Patients With Resected Brain Metastases: Clinical Outcomes and Comparing the Efficacy of Single-Fraction Radiosurgery and Fractionated Stereotactic Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 99(2). E118–E118. 1 indexed citations
13.
14.
Burton, Eric, Beatrice Ugiliweneza, Murali Kolikonda, et al.. (2017). A Regional Multicenter Retrospective Analysis of Patients with Primary Central Nervous System Lymphoma Diagnosed from 2000-2012: Treatment Patterns and Clinical Outcomes. Cureus. 9(7). e1512–e1512. 8 indexed citations
15.
Yusuf, Mehran, Mark J. Amsbaugh, Eric Burton, Jason Chesney, & Shiao Y. Woo. (2017). Peri-SRS Administration of Immune Checkpoint Therapy for Melanoma Metastatic to the Brain: Investigating Efficacy and the Effects of Relative Treatment Timing on Lesion Response. World Neurosurgery. 100. 632–640.e4. 44 indexed citations
16.
17.
Rubenstein, James L., Nancy J. Fischbein, Ken Aldape, Eric Burton, & Marc Shuman. (2002). Hemorrhage and VEGF Expression in a Case of Primary CNS Lymphoma. Journal of Neuro-Oncology. 58(1). 53–56. 34 indexed citations
18.
Burton, Eric & Michael D. Prados. (2000). Malignant gliomas. Current Treatment Options in Oncology. 1(5). 459–468. 90 indexed citations
19.
Maybaum, Jonathan, Eric Burton, David Shelton, et al.. (1991). Divergent patterns of incorporation of bromodeoxyuridine and iododeoxyuridine in human colorectal tumor cell lines. Biochemical Pharmacology. 42(1). 131–137. 13 indexed citations
20.
Hafner, Mikehl S., et al.. (1989). Response of human HT-29 colorectal tumor cells to extended exposure to bromodeoxyuridine. Cancer Chemotherapy and Pharmacology. 25(1). 45–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuriko Minn Breakdown of academic impact, for papers by Paul L. Moots Breakdown of academic impact, for papers by Young Zoon Kim Breakdown of academic impact, for papers by Jasper Chen Breakdown of academic impact, for papers by Konstantinos Gousias Breakdown of academic impact, for papers by Kiyoshi Onda Breakdown of academic impact, for papers by Tomoyuki Koga Breakdown of academic impact, for papers by Takafumi Ide Breakdown of academic impact, for papers by Seon‐Jin Yoon
Rankless by CCL
2026